News|Articles|June 26, 2026

5 Essential Capabilities for Decentralized Clinical Trials

Key Takeaways

Decentralized clinical trials are positioned as a foundational competency as clinical research continues shifting toward broader access and real-world evidence generation.
Expanded participation is enabled by reducing geographic and logistical barriers for patients, supporting more inclusive enrollment and retention.
Trial efficiency can improve through streamlined remote processes, but only when operational execution is intentionally designed for decentralization.
Successful delivery requires a comprehensive strategy addressing data integrity, compliance, participant experience, and coordinated technology-enabled workflows across distributed stakeholders.

As the clinical research landscape evolves, decentralized clinical trials (DCTs) have emerged as a foundational competency, enabling broader patient participation, increasing trial efficiency, and driving more inclusive, real-world data collection. However, the successful execution of DCTs requires more than just innovative technology—it demands a comprehensive strategy that addresses the unique challenges of decentralization.

Download Whitepaper

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.